(Q36633620)

15 August 2017

1 reference

title

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission (English)

1 reference

15 August 2017

0 references

0 references

Muller N

1

1 reference

15 August 2017

Schwarz M

series ordinal

2

1 reference

15 August 2017

publication date

1 October 2006

1 reference

15 August 2017

published in

Neurotoxicity Research

1 reference

15 August 2017

volume

10

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

131-148

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033242

15 August 2017

exact match

0 references

cites work

Schizophrenia, sensory gating, and nicotinic receptors

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Should schizophrenia be treated as a neurocognitive disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Adult schizophrenia following prenatal exposure to an influenza epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

M-1/M-2 macrophages and the Th1/Th2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Negative association between schizophrenia and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033242

Activated human microglia produce the excitotoxin quinolinic acid

21 January 2018

1 reference

12 December 2020

The etiopathogenesis of schizophrenias

1 reference

12 December 2020

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

12 December 2020

Seasonality of births in schizophrenia and bipolar disorder: a review of the literature

1 reference

12 December 2020

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

12 December 2020

Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain.

1 reference

12 December 2020

Association between prenatal exposure to poliovirus infection and adult schizophrenia.

1 reference

12 December 2020

Interleukin-1 alpha in blood has direct access to cortical brain cells

1 reference

12 December 2020

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

1 reference

12 December 2020

Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms

1 reference

12 December 2020

The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia.

1 reference

12 December 2020

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

1 reference

12 December 2020

Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?

1 reference

12 December 2020

Increased cortical kynurenate content in schizophrenia

1 reference

12 December 2020

Exposure to Prenatal and Childhood Infections and the Risk of Schizophrenia

1 reference

12 December 2020

Viruses, schizophrenia, and bipolar disorder

1 reference

12 December 2020

Is schizophrenia a neurodevelopmental disorder?

1 reference

12 December 2020

Production of cytokines in acute schizophrenic psychosis

1 reference

12 December 2020

Decreased T cellular immune response in schizophrenic patients.

1 reference

12 December 2020

Schizophrenia and B-lymphocyte alteration--a hypothesis

1 reference

12 December 2020

Antibodies to infectious agents in individuals with recent onset schizophrenia

1 reference

12 December 2020

Potential role for the narcolepsy- and multiple sclerosis-associated HLA allele DQB1*0602 in schizophrenia subtypes

1 reference

12 December 2020

The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases

1 reference

12 December 2020

Cytokine production in drug-free and neuroleptic-treated schizophrenic patients

1 reference

12 December 2020

Immunological and infectious aspects of schizophrenia

1 reference

12 December 2020

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

12 December 2020

Management of the negative symptoms of schizophrenia: new treatment options

1 reference

12 December 2020

No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia.

1 reference

12 December 2020

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

12 December 2020

IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia

1 reference

12 December 2020

Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes

1 reference

12 December 2020

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology

1 reference

12 December 2020

Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture

1 reference

12 December 2020

Biology of human TH1 and TH2 cells

1 reference

12 December 2020

The genetics of schizophrenia: glutamate not dopamine?

1 reference

12 December 2020

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia

1 reference

12 December 2020

Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up

1 reference

12 December 2020

Epidemiology of schizophrenia: the global burden of disease and disability

1 reference

12 December 2020

Clinical and laboratory evidence of autoimmunity in acute schizophrenia

1 reference

12 December 2020

Muscarinic receptor stimulation reduces NMDA responses in CA3 hippocampal pyramidal cells via Ca2+-dependent activation of tyrosine phosphatase.

1 reference

12 December 2020

Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation

1 reference

12 December 2020

Kynurenic acid and schizophrenia

1 reference

12 December 2020

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

12 December 2020

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

1 reference

12 December 2020

Identification of tryptophan 2,3-dioxygenase RNA in rodent brain.

1 reference

12 December 2020

Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms

1 reference

12 December 2020

Significant frequency deviation of the class I polymorphism HLA-A10 in schizophrenic patients

1 reference

12 December 2020

Evidence for activation of microglia in patients with psychiatric illnesses

1 reference

12 December 2020

Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+ gamma/delta+) in unmedicated schizophrenic patients: relation to impairment of the blood-brain barrier and HLA-DPA*02011.

1 reference

12 December 2020

Maternal infections and subsequent psychosis among offspring.

1 reference

12 December 2020

Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families

1 reference

12 December 2020

Analysis of a polymorphism in the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia

1 reference

12 December 2020

Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

1 reference

12 December 2020

Environmental risk factors for psychosis.

1 reference

12 December 2020

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia.

1 reference

12 December 2020

S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia

1 reference

12 December 2020

S100B in schizophrenic psychosis

1 reference

12 December 2020

Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Aspects of normal cerebrospinal fluid circulation and circumventricular organs.

1 reference

12 December 2020

Cytokines production in chronic schizophrenia patients with or without paranoid behaviour.

1 reference

12 December 2020

The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and co-activation

1 reference

12 December 2020

Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark

1 reference

12 December 2020

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

12 December 2020

Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme

1 reference

12 December 2020

The inflammatory reflex

1 reference

12 December 2020

L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat.

1 reference

12 December 2020

Genetics of susceptibility to human infectious disease

1 reference

12 December 2020

In vivo immunomodulatory effects of clozapine in schizophrenia

1 reference

12 December 2020

Serum interleukin-18 levels are elevated in schizophrenia

1 reference

12 December 2020

Indomethacin induced psychosis

1 reference

12 December 2020

Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study

1 reference

12 December 2020

Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality

1 reference

12 December 2020

Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia

1 reference

12 December 2020

Childhood central nervous system infections and risk for schizophrenia

1 reference

12 December 2020

Nicotinic receptors regulate B lymphocyte activation and immune response

1 reference

12 December 2020

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

1 reference

12 December 2020

Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib–pair linkage analysis

1 reference

12 December 2020

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

12 December 2020

IL-12 production by central nervous system microglia is inhibited by astrocytes.

1 reference

12 December 2020

Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients

1 reference

12 December 2020

[CSF Filtration as Experimental Therapy in Therapyresistant Psychoses in Borna Disease Virus-Seropositive Patients]

1 reference

12 December 2020

Childhood meningitis, brain maturation and the risk of psychosis

1 reference

12 December 2020

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

12 December 2020

Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients

1 reference

12 December 2020

Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia

1 reference

12 December 2020

Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.

1 reference

12 December 2020

The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis

1 reference

12 December 2020

A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6

1 reference

12 December 2020

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

1 reference

12 December 2020

Association of neuregulin 1 with schizophrenia confirmed in a Scottish population

1 reference

12 December 2020

Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring

1 reference

12 December 2020

Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus

1 reference

12 December 2020

Cortical cholinergic transmission and cortical information processing in schizophrenia

1 reference

12 December 2020

Neuropharmacology of quinolinic and kynurenic acids

1 reference

12 December 2020

Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex

1 reference

12 December 2020

Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia

1 reference

12 December 2020

Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase

1 reference

12 December 2020

Increased soluble endothelial adhesion molecules in rheumatoid arthritis correlate with circulating cytokines and depletion of CD45RO+ T-lymphocytes from blood stream

1 reference

12 December 2020

Tolerance, DCs and tryptophan: much ado about IDO

1 reference

12 December 2020

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

12 December 2020

Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice

1 reference

12 December 2020

The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans

1 reference

12 December 2020

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

1 reference

12 December 2020

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

12 December 2020

Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms

1 reference

12 December 2020

Cholinergic systems and schizophrenia: primary pathology or epiphenomena?

1 reference

12 December 2020

Atypical antipsychotics: matching receptor profile to individual patient's clinical profile

1 reference

12 December 2020

Antipsychotic drugs, neurotransmitters, and schizophrenia

1 reference

12 December 2020

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

1 reference

12 December 2020

On the production and disposition of quinolinic acid in rat brain and liver slices.

1 reference

12 December 2020

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

1 reference

12 December 2020

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?

1 reference

12 December 2020

Influence of therapy on antibody-formation

1 reference

12 December 2020

Genetics and genomics in infectious disease susceptibility

1 reference

12 December 2020

Prostaglandins as modulators of immunity

1 reference

12 December 2020

Elevated plasma prostaglandin E2 levels in schizophrenia

1 reference

12 December 2020

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

12 December 2020

Neuregulin 1 and susceptibility to schizophrenia

1 reference

12 December 2020

D-serine added to antipsychotics for the treatment of schizophrenia

1 reference

12 December 2020

(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats.

1 reference

12 December 2020

Prediction of the ability of clozapine to treat negative symptoms from plasma glycine and serine levels in schizophrenia

1 reference

12 December 2020

Kynurenate production by cultured human astrocytes

1 reference

12 December 2020

Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia.

1 reference

12 December 2020

Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients

1 reference

12 December 2020

Neuregulin and ErbB receptor signaling pathways in the nervous system

1 reference

12 December 2020

Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring

1 reference

12 December 2020

Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease

1 reference

12 December 2020

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

1 reference

12 December 2020

The S100 protein family: history, function, and expression

1 reference

12 December 2020

An analysis of lymphocyte subpopulations in schizophrenic patients

1 reference

12 December 2020

Modulation of T-cell cytokine secretion by accessory cell-derived products.

1 reference

12 December 2020

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects.

1 reference

12 December 2020

Psychiatric side effects of indomethacin in parturients

1 reference

12 December 2020

Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia.

1 reference

12 December 2020

Clinical effects of COX-2 inhibitors on cognition in schizophrenia.

1 reference

12 December 2020

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF.

1 reference

12 December 2020

Heritability estimates for psychotic disorders: the Maudsley twin psychosis series

1 reference

12 December 2020

Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation.

1 reference

12 December 2020

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

1 reference

12 December 2020

T-helper-1 and T-helper-2 responses in psychiatric disorders

1 reference

12 December 2020

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

1 reference

12 December 2020

Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat.

1 reference

12 December 2020

Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin

1 reference

12 December 2020

Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice

1 reference

12 December 2020

Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia

1 reference

12 December 2020

Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes

1 reference

12 December 2020

Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.

1 reference

12 December 2020

3-Hydroxyanthranilic acid as an intermediate in the oxidation of the indole nucleus of tryptophan

1 reference

12 December 2020

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

12 December 2020

Cognitive and behavioral precursors of schizophrenia.

1 reference

12 December 2020

Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship

1 reference

12 December 2020

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

1 reference

12 December 2020

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

1 reference

12 December 2020

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

1 reference

12 December 2020

ICAM G241A polymorphism and soluble ICAM-1 serum levels: evidence for an active immune process in schizophrenia

1 reference

12 December 2020

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

1 reference

12 December 2020

Increased phencyclidine-induced hyperactivity following cortical cholinergic denervation

1 reference

12 December 2020

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization

1 reference

12 December 2020

T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment

1 reference

12 December 2020

Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.

1 reference

12 December 2020

Psychotropic effects of COX-2 inhibitors--a possible new approach for the treatment of psychiatric disorders

1 reference

12 December 2020

Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment

1 reference

12 December 2020

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

1 reference

12 December 2020

Nicotinic receptors in the brain. Links between molecular biology and behavior.

1 reference

12 December 2020

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients.

1 reference

12 December 2020

Genetics of infectious disease resistance

1 reference

12 December 2020

Smoking and schizophrenia

1 reference

12 December 2020

Serologic evidence of prenatal influenza in the etiology of schizophrenia

1 reference

12 December 2020

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

1 reference

12 December 2020

Cellular immunity in schizophrenic patients before and during neuroleptic treatment

1 reference

12 December 2020

Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033242

1 reference

15 August 2017

1 reference